Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT00879658 · COMPLETED
Trial details
- NCT number
- NCT00879658
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-30
- Primary completion
- 2011-05-04
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.